Cardiovascular risk assessment and risk factor control in patients with hypertension in Europe: the SNAPSHOT study
Authors' conclusion
Physicians from six European countries tended to overestimate control rates of BP and LDL cholesterol, while underestimating CV risk in their patients with hypertension. Overall, BP, LDL cholesterol, and glycated haemoglobin control rates were low. Better implementation of clinical guideline recommendations is needed.
Study context
- Population
- Adults with hypertension in routine clinical practicepatients (aged 65.8 ± 10.5 years, 43.1% male)
- Participants
- 9,307 adults
- Exposure
- Assessment of patient cardiovascular (CV) risk by physicians relative to the risk obtained using SCORE1 and SCORE2/SCORE2-OP
- Outcome
- Patient characteristics
Methodological detailsconducted in Bulgaria, Croatia, Georgia, Romania, Serbia, and Spain
- Conducted in Bulgaria, Croatia, Georgia, Romania, Serbia, and Spain
Main finding
As reported in the abstract
≥1 additional CV risk factor
91.3%
Dyslipidaemia
7610
81.8%
Type 2 diabetes (T2D)
3097
33.3%
Observational data: associations, not effects.
Further findings
Physician assessment of CV risk relative to SCORE1 and SCORE2/SCORE2-OP
- Accurate, relative to SCORE1
- 38.0
- Accurate, relative to SCORE2/SCORE2-OP
- 26.7%
- Underestimated, relative to SCORE1
- 54.3
- Underestimated, relative to SCORE2/SCORE2-OP
- 71.8%
Control rates of blood pressure (BP), LDL cholesterol, and glycated haemoglobin
- BP control rate
- <25%
- LDL cholesterol control rate (in those with comorbid dyslipidaemia)
- <12%
- Glycated haemoglobin control rate (in those with comorbid T2D)
- <50%
- Suboptimal
Original publication
Cardiovascular risk assessment and risk factor control in patients with hypertension in Europe: the SNAPSHOT study. Eur Heart J Qual Care Clin Outcomes. Published 19 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →